Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Acute Lymphoblastic Leukemia
70%
Bone Marrow Transplantation
47%
Childhood Acute Lymphoblastic Leukemia
41%
Neuroblastoma
33%
Bone Marrow
25%
Gene Therapy
21%
Relapsed Acute Lymphoblastic Leukemia
21%
Methotrexate
20%
Allogeneic Bone Marrow Transplantation
20%
Pediatric Cancer Patients
19%
High Risk
18%
Macrophages
18%
Twitcher Mouse
17%
Transplantation
17%
Event-free Survival
16%
Dutch
15%
Pediatric Patients
15%
BCP-ALL
14%
Anti-GD2 Antibody
14%
Stem Cell Transplantation
14%
Minimal Residual Disease
14%
Hemopoietic Stem Cells
13%
Chemotherapy
13%
IKZF1 Deletion
13%
Vorinostat
13%
Overall Survival
13%
Risk Factors
12%
Neuroblastoma Cells
12%
Clinical Trials
11%
Oncology
11%
Adenosine Deaminase Deficiency
11%
Rat Model
11%
Adenosine Deaminase
11%
Gaucher Disease
11%
Retroviral Vector
11%
Immunocombination Therapy
11%
Pediatric Tumors
11%
T Cells
11%
Bone Marrow Cells
11%
ETV6-RUNX1
11%
High-risk Neuroblastoma
10%
Working Diagnosis
10%
Stem Cell Gene Therapy
9%
Rhesus Monkey
9%
Central Nervous System
9%
During Treatment
9%
Leukemia
9%
Clinical High Risk
9%
Histone Deacetylase Inhibitor (HDACi)
9%
BTG1
9%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Leukemia
35%
Childhood Cancer
33%
Pediatrics
31%
Quality of Life
26%
Diseases
24%
Malignant Neoplasm
24%
Bone Marrow Transplantation
23%
Ganglioneuroblastoma
23%
Bone Cancer
23%
Oncologist
23%
B Cell
21%
Chemotherapy
20%
Allogenic Bone Marrow Transplantation
20%
Precursor
20%
Minimal Residual Disease
19%
Event Free Survival
16%
Oncology
15%
Overall Survival
14%
Echocardiography
13%
Anthracycline
12%
Hematologic Malignancy
12%
Genetics
12%
Neoplasm
12%
Lysosomal Storage Disease
11%
Osteosarcoma
11%
Observational Study
11%
Survival Rate
11%
Brain Natriuretic Peptide
9%
Enzymes
9%
Pediatrics Patient
9%
Acute Lymphocytic Leukemia
9%
Central Nervous System
8%
Adolescence
8%
Amino Terminal Sequence
7%
Prospective Study
7%
Pediatric Oncologist
7%
Ablation Therapy
7%
Methotrexate
7%
Stem Cell Therapy
7%
Congestive Heart Failure
7%
Allograft
7%
Cancer
6%
T Cell
6%
Neurologic Disease
6%
High Risk Population
6%
Physical Activity
6%
Engraftment
6%
Disease Course
6%
Hematopoietic Stem Cell Transplantation
6%
Biochemistry, Genetics and Molecular Biology
Pediatrics
62%
B Cell
62%
Precursor
60%
IKZF1
47%
Genomics
39%
Genetics
23%
Gene Expression
21%
Tumor Suppressor Protein
17%
ETV6
17%
Germ Cell
16%
RUNX1
16%
Germline
14%
Real-Time Polymerase Chain Reaction
13%
Gene Translocation
11%
Cytogenetics
10%
PTPN11
9%
Messenger RNA
9%
High Risk Population
8%
Histone Deacetylase
7%
Clonal Evolution
7%
Macrophage
7%
Transcription
7%
Expression Level
7%
PRMT1
7%
Germline Mutation
6%
Single-Nucleotide Polymorphism
6%
Metabolic Pathway
6%
Knockout Mouse
6%
Cell Cycle Progression
6%
Isoform
6%
Gene Frequency
6%
Hematopoietic Cell
6%
Asparaginase
5%
Corticosteroid
5%
Glucocerebrosidase
5%
Low Density Lipoprotein Receptor Knockout Mouse
5%
Gaucher's Disease
5%
Glucosylceramidase
5%
Disease Classification
5%
Lipoprotein Metabolism
5%
LDL Receptor
5%
Histone Deacetylases Inhibitor
5%
Catabolism
5%
Sialic Acid
5%
Exome Sequencing
5%
Thiopurine Methyltransferase
5%
Triacylglycerol Lipase
5%
Pancreatic Lipase
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Transgenic Mouse
5%
